The results above have shown C/EBPβ PARylation inhibits its SUMOylation at K134 site, SUMO1 and PARP1 play opposite roles during the process of cardiac hypertrophy depends on C/EBPβ K134 SUMOylation and PARylation. The gene discussed is PARP1; the disease is cardiac hypertrophy.